• NeuroPace will attend the ASSFN Meeting in Cleveland, Ohio, running May 29–June 2, 2026.
• Company plans to highlight long-term RNS System outcomes, NAUTILUS results in idiopathic generalized epilepsy, supported by data-driven clinical tools.
• A breakfast symposium on thalamic neuromodulation is scheduled for June 1, 2026, 7:00 a.m. ET.
• NeuroPace will support an epilepsy surgery education course on May 30, 2026, 8:30 a.m.–12:00 p.m. ET.
• Booth demonstrations and physician feedback sessions are planned throughout the meeting, including a preview of the FDA-cleared ECoG Assistant tool.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuropace Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260529755564) on May 29, 2026, and is solely responsible for the information contained therein.